Nebivalve 2.5

Nebivolol is generally not recommended during pregnancy unless a healthcare professional determines that treatment is necessary. If you are pregnant, planning pregnancy, or suspect pregnancy, consult your doctor to assess potential risks and discuss suitable alternatives.

The safety of Nebivolol during breastfeeding has not been adequately established. Consult your doctor before using this medicine while nursing, as an alternative may be preferable. Your healthcare professional can evaluate potential risks and recommend appropriate treatment.

Nebivolol may cause dizziness, tiredness, or lightheadedness, particularly when starting treatment or changing the dose. Avoid driving or operating machinery if these symptoms affect your alertness. Resume these activities only when you feel well and can do so safely.

Patients with kidney disease should inform their doctor before taking Nebivolol. Reduced kidney function may require careful dose selection, particularly in severe impairment. Your healthcare professional can assess kidney function, monitor blood pressure, and determine the appropriate treatment plan.

Patients with liver disease should consult their doctor before using Nebivolol. Because the medicine is processed by the liver, impaired liver function can affect its handling in the body. Nebivolol may be unsuitable in severe liver impairment, so medical assessment is essential.